Status:
COMPLETED
Examining the Use of a Novel Immersive Motion Tracking Upper Extremity Exercise Program for Acute Hospitalized Patients
Lead Sponsor:
NYU Langone Health
Conditions:
Kidney Transplant
Liver Transplant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study is to evaluate the feasibility of the MoveMend Health software program as an integrated supplement to traditional acute care/in-hospital occupational therapy for patients f...
Eligibility Criteria
Inclusion
- English speaking (software program is currently only available in English)
- Status post kidney or liver transplant this admission
- Physician orders for occupational therapy evaluation and treatment
- Orientation Log \> 25
- Negative for delirium per the Confusion Assessment Method
Exclusion
- Orthopedic or surgical precautions that limits shoulder range of motion beyond 90 degrees
- Upper extremity hemiplegia with inability to lift upper extremity against gravity
- Accommodation code of Intensive Care Unit
Key Trial Info
Start Date :
August 6 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 27 2024
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT06222554
Start Date
August 6 2024
End Date
November 27 2024
Last Update
April 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016